Ratings by Citi (Laura Sutcliffe)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/18/2025 ResMed RMD New Coverage Buy
(N/A)
271.71
(191.26)
-29.61% Details
9/18/2025 Telix Pharmaceuticals Ltd TLX New Coverage Buy
(N/A)
9.38
(10.21)
8.85% Details